Concepedia

Publication | Closed Access

Human Recombinant DNA–Derived Antihemophilic Factor (Factor VIII) in the Treatment of Hemophilia A

DOI

263

Citations

15

References

1990

Year

Richard S. Schwartz, Charles F. Abildgaard, Louis M. Aledort, Steven Arkin, A. L. Bloom, H.‐H. Brackmann, Doreen B. Brettler, Hiromu Fukui, Margaret W. Hilgartner, Martin J. Inwood,
New England Journal of Medicine

Abstract

Recombinant factor VIII has biologic activity comparable to that of plasma factor VIII and is safe and efficacious for the treatment of hemophilia A.

References

YearCitations

Page 1